Nevertheless, as many studies have emphatically shown that CDK5 is critical for pancreatic cancer progression, the clinical significance of CDK5-mediated EZH2 degradation needs to be explored further. This evidence concerns the gene EZH2 and familial pancreatic carcinoma.